MDWD — MediWound Ltd.
—
Nasdaq ·
Materials ·
Chemicals ·
CIK 1593984 ·
Last close
$13.84
Market Cap
$178.68M
52W High
$20.03
52W Low
$12.52
ADV30
105,167
Next earnings
2026-11-19
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 3,092,000 | 337,000 | -9,458,000 | -7,392,000 | 71,879,000 | — | 36,235,000 |
| Mar 2026 | 1,475,000 | 323,000 | -7,980,000 | -2,952,000 | 79,982,000 | — | 38,559,000 |
| Dec 2025 | 1,867,000 | 278,000 | -7,813,000 | -7,183,000 | 86,255,000 | 4,799,000 | 42,623,000 |
| Sep 2025 | 5,429,000 | 896,000 | -6,525,000 | -2,652,000 | 94,423,000 | — | 44,267,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,765,000
Investing CF
$3,149,000
Financing CF
$29,561,000
CapEx
$-6,366,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.26
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-228,925,000
Inventory
$4,772,000
Receivables
$2,748,000
ST Investments
$48,341,000
EBIT TTM
$-26,085,000
Pretax Income TTM
$-25,958,000
Interest Exp TTM
$7,564,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,863,000
EBITDA
$-30,749,000
Free Cash Flow
$-29,048,876
Enterprise Value
$142,517,744
Total Cash
$35,341,000
Total Debt
$8,605,000
Shares Out
12,910,278
Trailing EPS
$-2.16
Book Value
$2.76
ROE
-72.4%
ROA
-28.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,959,000 | -25,279,000 | -23,879,000 | 86,255,000 | 42,623,000 | 43,632,000 | -16,121,000 |
| Dec 2024 | 20,222,000 | -19,382,000 | -30,224,000 | 73,496,000 | 42,343,000 | 31,153,000 | -13,624,000 |
| Dec 2023 | 18,686,000 | -15,501,000 | -6,716,000 | 66,459,000 | 34,864,000 | 31,595,000 | -10,465,000 |
| Dec 2022 | 26,496,000 | -7,661,000 | -19,599,000 | 50,016,000 | 39,102,000 | 10,914,000 | -11,885,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.29
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $13.91 · call volume: 89 · put volume: 95
Expected Move to 2026-12-18:
±$3.42
(24.59%) —
implied range
$10.49 –
$17.33
· ATM straddle on $14.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LODE | Comstock Inc. | $194.54M | $2.56 | — |
| YSG | Yatsen Holding Ltd | $161.98M | $2.54 | — |
| SAFX | XCF Global, Inc. | $153.60M | $0.37 | — |
| CDXS | CODEXIS, INC. | $144.55M | $1.32 | — |
| FF | FutureFuel Corp. | $224.58M | $5.12 | — |
News headlines (Yahoo Finance, 1h cache)
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
2026-09-22 11:00 · Yahoo
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
2026-09-14 11:00 · Yahoo
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-02 11:00 · Yahoo
MediWound (MDWD) Q2 2026 Earnings Call Transcript
2026-08-20 12:42 · Yahoo
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ...
2026-08-13 23:07 · Yahoo
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-08-13 11:00 · Yahoo
MediWound to Report Second Quarter 2026 Financial Results
2026-07-29 12:00 · Yahoo
Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely?
2026-05-28 12:53 · Yahoo
MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ...
2026-05-27 21:00 · Yahoo
MediWound (MDWD) Q1 2026 Earnings Transcript
2026-05-27 18:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.